Vericel Corp (VCEL) stock
VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/30240% above fair value
$56.96−0.46 (-0.80%)
Close on Nov 13, 2026Market cap $2.92BP/E 96.5Yield –
Vericel profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Vericel's profit margin for the twelve months ending Sep 30, 2026 was 10.3%. For fiscal 2025 it was 6.0%, against 4.4% the year before. The highest annual figure on record is 6.0% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.0% | +1.6 |
| FY2024 | Dec 31, 2024 | 4.4% | +6.0 |
| FY2023 | Dec 31, 2023 | -1.6% | +8.6 |
| FY2022 | Dec 31, 2022 | -10.2% | −5.4 |
| FY2021 | Dec 31, 2021 | -4.8% | −7.1 |
| FY2020 | Dec 31, 2020 | 2.3% | +10.5 |
| FY2019 | Dec 31, 2019 | -8.2% | +0.8 |
| FY2018 | Dec 31, 2018 | -9.0% | +18.1 |
| FY2017 | Dec 31, 2017 | -27.0% | +8.9 |
| FY2016 | Dec 31, 2016 | -36.0% | −4.0 |
| FY2015 | Dec 31, 2015 | -31.9% | +37.2 |
| FY2014 | Dec 31, 2014 | -69.2% | +82151.9 |
| FY2013 | Dec 31, 2013 | -82221.1% | +58131.3 |
| FY2012 | Dec 31, 2012 | -140352.4% | −123995.1 |
| FY2010 | Jun 30, 2010 | -16357.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 16.6% | +9.1 |
| Q2 FY2026 | Jun 30, 2026 | 2.8% | +3.7 |
| Q1 FY2026 | Mar 31, 2026 | -9.2% | +12.2 |
| Q4 FY2025 | Dec 31, 2025 | 25.0% | −1.3 |
| Q3 FY2025 | Sep 30, 2025 | 7.5% | +9.1 |
| Q2 FY2025 | Jun 30, 2025 | -0.9% | +8.0 |
| Q1 FY2025 | Mar 31, 2025 | -21.4% | −13.8 |
| Q4 FY2024 | Dec 31, 2024 | 26.3% | +6.3 |
| Q3 FY2024 | Sep 30, 2024 | -1.6% | +6.5 |
| Q2 FY2024 | Jun 30, 2024 | -8.9% | +2.0 |
| Q1 FY2024 | Mar 31, 2024 | -7.5% | +10.7 |
| Q4 FY2023 | Dec 31, 2023 | 20.0% | +8.8 |
| Q3 FY2023 | Sep 30, 2023 | -8.0% | +9.0 |
| Q2 FY2023 | Jun 30, 2023 | -10.9% | +13.3 |
| Q1 FY2023 | Mar 31, 2023 | -18.3% | +1.4 |
| Q4 FY2022 | Dec 31, 2022 | 11.2% | +1.7 |
| Q3 FY2022 | Sep 30, 2022 | -17.1% | −2.8 |
| Q2 FY2022 | Jun 30, 2022 | -24.2% | −14.6 |
| Q1 FY2022 | Mar 31, 2022 | -19.7% | −10.1 |
| Q4 FY2021 | Dec 31, 2021 | 9.5% | −17.5 |
| Q3 FY2021 | Sep 30, 2021 | -14.3% | −25.5 |
| Q2 FY2021 | Jun 30, 2021 | -9.6% | +31.7 |
| Q1 FY2021 | Mar 31, 2021 | -9.5% | +8.1 |
| Q4 FY2020 | Dec 31, 2020 | 27.0% | +2.9 |
| Q3 FY2020 | Sep 30, 2020 | 11.2% | −0.2 |
| Q2 FY2020 | Jun 30, 2020 | -41.3% | +34.4 |
| Q1 FY2020 | Mar 31, 2020 | -17.6% | −4.6 |
| Q4 FY2019 | Dec 31, 2019 | 24.1% | +7.4 |
| Q3 FY2019 | Sep 30, 2019 | 11.4% | +16.1 |
| Q2 FY2019 | Jun 30, 2019 | -75.7% | −51.2 |
| Q1 FY2019 | Mar 31, 2019 | -13.0% | +29.4 |
| Q4 FY2018 | Dec 31, 2018 | 16.7% | +15.5 |
| Q3 FY2018 | Sep 30, 2018 | -4.8% | +33.2 |
| Q2 FY2018 | Jun 30, 2018 | -24.5% | −10.4 |
| Q1 FY2018 | Mar 31, 2018 | -42.5% | +62.0 |
| Q4 FY2017 | Dec 31, 2017 | 1.2% | +0.0 |
| Q3 FY2017 | Sep 30, 2017 | -37.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -14.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -104.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 1.2% | – |
See a number that looks wrong?